Clinical Trial

PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy

Name: PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy — clinical trial record (NCT07174375)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PCSK9-PROVE

Not Yet Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

This is a prospective, multicenter, randomized controlled clinical study to evaluate the efficacy of PCSK9 inhibitor in addition to standard therapy in patients with acute ischemic stroke undergoing endovascular therapy.

Trial Details

NCT Number	NCT07174375
Lead Sponsor	Nanfang Hospital, Southern Medical University
Conditions	Acute Ischemic Stroke
Enrollment	478 participants
Start Date	2025-09-15
Primary Completion	2027-12-15 (estimated)
Study Completion	2027-12-15 (estimated)
Updated on ClinicalTrials.gov	2025-09-15